Dogwood Therapeutics (DWTX) Preferred Shares (2023 - 2025)

Dogwood Therapeutics has reported Preferred Shares for 2 years, with the latest figure at $25.0 million in Q3 2025.

• On a quarterly basis, Preferred Shares changed N/A year-over-year to $25.0 million in Q3 2025; TTM through Sep 2025 was $25.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at $2.0 million, changed N/A from the prior year.
• Preferred Shares was $25.0 million for Q3 2025 at Dogwood Therapeutics, roughly flat from $25.0 million in the prior quarter.
• The five-year high for Preferred Shares was $25.0 million in Q1 2025, with the low at $2.0 million in Q4 2023.